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Cardiac output Increases by 30-50% during mammal Ian pregnancy. 
This Increase Is reflected by elevation In both heart rate and stroke 
volume. The primary mechanism of Increased stroke volume appears to 
be cardiac enlargement, rather than increased preload, afterload, or 
contractll lty. Animal studies have shown that enlargement of the 
heart occurs prior to an Increase In uterine blood flow during 
pregnancy and this type of enlargement can be mimicked by sex steroid 
adm In I strati on. 
2 
Systemic vascular resistance greatly decreases during pregnancy 
and with sex steroid administration. It has been postulated that 
systemic vascular resistance may be a signal for heart size changes. 
This study attempted to chronlcal ly decrease systemic vascular 
resistance by administration of an arterial vasodllator (hydralazlne) 
over a three week period to guinea pigs. At the time of study 
hemodynamlcs were measured which Included, heart rate, arterial 
pressure, right atrial pressure and cardiac output. In vitro left 
ventricular pressure volume relationships were also evaluated, as was 
total plasma volume. 
Systemic vascular resistance after 21 days was sl lghtly, though 
not statistically slgnlf lcantly, decreased (0.319 ± 0.071 vs. 0.360 ± 
0.088 Wood Units, p = n.s.>. This reflected a slight drop In mean 
arterial pressure (62 ± 8.6 vs. 64 ± 5.1 mm Hg, p = n.s.), as wel I as 
a sl lght Increase In cardiac oJtput (241 ± 34 vs. 230 ± 29 ml/min, p = 
n.s.). There was no detectable change Jn left ventricular chanber 
size as assessed by left ventricular pressure volume relationships. 
The difficulties of chronic pharmacologlc systemic vasodllatfon 
of the normal circulation are discussed with reference to the variety 
of compensatory mechanisms that are brought Into play. 
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REVIEW OF THE LITERATURE 
During pregnancy cardiac output Increases by 30-50% In al I 
mammals studied to date, Including humans (1-6). The time course of 
this Increase has been a topic of Investigation In the past, but most 
authorities report peak values by the second trimester (1,2). The 
determinants of cardiac output, stroke volume and heart rate, both 
increase during pregnancy (1,2). However, mechanisms responsible for 
these changes have been Inadequately explained. Recent studies from 
our laboratory In the Pygmy goat suggest that the heart rate Increase 
may be both mediated autonomlcal ly as wel I as mediated through a 
change In Intrinsic sinus node automatlcity (4). The Increase In 
stroke volume Is also not agreed upon. The potential mechanisms by 
which stroke volume could be Increased are preload, afterload, and 
contractil tty. 
Many studies have shown a 40-50% Increase In blood volume during 
pregnancy (2,7,8,9). This would seem to suggest that Increased 
preload (sarcomere length at the end of diastole) may be Important to 
Increased cardiac output. However, Infusion of whole blood or dextran 
In amounts sufficient to double left ventricular fll ling pressure have 
shown only smal I changes In left ventricular dimensions, stroke 
volume, and cardiac output (10,11). This evidence suggests that an 
Increase In preload from Increased blood volume contributes I lttle to 
Increased stroke.volume during pregnancy. Moreover, studies in women 
(12) and pregnant guinea pigs (13) have failed to show Increased 
filling pressures. 
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Left ventricular function has been assessed by noninvasive 
measurements of contractll lty such as systolic time Intervals and 
echocardlographlc ejection phase Indices. Results from systol le time 
Interval studies have not been consistent. In one study Rubier et al. 
reported that the Isometric contraction period was shorter during the 
third trimester of pregnancy than postpartum and concluded that left 
ventricular contractll lty was greater during pregnancy (14). Burg et 
al. also measured systol le time Intervals and reported a prolonged 
pre-ejection period and a shortened left ventricular ejection time, 
suggesting Impaired left ventricular performance (15). A recent 
serial echocardlographlc study has shown that left ventricular 
performance Is not changed during pregnancy (16). In addition, data 
suggest that calculations by systolic time Intervals are Influenced by 
maternal position (15,16). However, since these methods are sensitive 
to changes In preload and afterload, conclusions about ventricular 
function during pregnancy need qual lficatlon (17). 
Changes In afterload are also difficult to evaluate. Afterload 
Is probably best approximated by wal I stress of the ventricle. The 
parameters of left ventricular wal I stress are left ventricular 
chamber size and wal I thickness (La Place), and systemic vascular 
resistance (18). Other factors also Include rate of ventricular 
emptying and aortic Impedance (18). During pregnancy the left 
ventricular chamber size to wal I thickness ratio Increases which would 
tend to Increase afterload. However, systemic vascular resistance and 
aortic Impedance are reduced as Is left ventricular ejection time 
(16), factors al I tending to reduce afterload. 
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A fourth determinant of stroke volume, ventricular enlargement, 
was shown as early as 1825 to occur In pregnancy (19). With a larger 
heart, none of the traditional determinants of stroke volume need play 
a role. Experiments of near term guinea pig pregnancy have shown that 
the left ventricle Is remodeled so that Its volume Is larger at any 
given fll ling pressure (13). Enlargement of the heart would have the 
advantage of Increasing stroke volume without changing f 11 I Ing 
pressure and would not change the short term operating mechanisms for 
stroke volume so that preload, contractll lty, and afterload could 
stll I change In accordance to cardiovascular demands. 
Morphologic changes of the heart are not unique to pregnancy. 
Increased heart size and mass are observed In response to vigorous 
physical activity. In an echocardlographlc study of 56 trained 
athletes, Morganroth et al. compared left ventricular end dlastol le 
pressure CLVEDP) to wal I thickness ratios In both isotonic and 
isometric exercise groups to control groups (20). Morganroth and his 
col leagues also calculated heart mass. Results showed that the 
Isotonic exercise group Increased LVEDP and heart mass but not wal I 
thickness compared to controls. Athletes Involved In Isometric 
exercise Increased wal I thickness and mass but left ventricular end 
dlastol le volume CLVEDV) did not change slgnlf lcantly. In a study of 
chronic volume overload caused by arterlovenous CA-V) fistula on dogs, 
Ross showed a thicker, more massive heart developed although 
contractll lty did not change. When the fistula was removed, hearts 
returned to normal states (21). The lmpl I cations of these results are 
two fold. The heart responds chronlcal ly to Increased cardiovascular 
demands by morphologic changes. Also the morphologic changes are 
demand specif Jc. 
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The mechanisms for cardiac enlargement during pregnancy have not 
been adequately explained. One of the f lrst hypotheses for enlarge-
ment during pregnancy was presented by Burwel I In 1938 C22). He 
proposed that the placenta acts as an A-V f lstula. Blood flow through 
the placenta Is parallel to maternal clrculatlon; thus, blood pressure 
Is lowered and other circulatory changes may be a result of this. 
Some hemodynamlc changes seen Jn pregnancy, such as Increased heart 
rate and cardiac output, and decreased A-V oxygen difference, are also 
characteristics of an A-V fistula. Although this concept was widely 
accepted tor many years, there are problems with this Interpretation. 
The cardiac enlargement produced by experimental A-V f Jstula is 
dlsslmllar to that seen In pregnancy as fll ling pressures are markedly 
elevated (21,23). Furthermore, Hart et al. have shown that blood 
volume, cardiac output, stroke volume and heart size are al I Increased 
during the first trimester of guinea pig pregnancy, wel I before a 
change in uterine blood flow takes place (13). The increase Jn left 
ventricular chcmber s!ze was associated with an increase Jn the ratio 
of left ventricular chamber radius TO wal I thickness, a morphologic 
change previously described as being associated with pregnancy (16). 
Table I compares the cardiac enlargement associated with pregnancy to 
other known conditions associated with cardiac enlargement. As can be 
seen, the cardiac enlargement associated with pregnancy appears to be 
a unique physlologlc adaptation. 
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TABLE I. TABLE OF CHANGES 
Stroke-Vol. LVEDP LVED Diam. LV Wa 11 
Thickness 
Radius-Wall 
Thickness 
Pregnancy t --- t t 
Expt. AV Fistula t t t ? ? 
Isotonic Training t --- t t 
Isometric Training --- --- --- tt H 
Hormones have long been known to be powerful mediators of 
control mechanisms. Estrogen and progesterone levels are elevated In 
pregnancy. The corpus tuteum and the placenta both contribute to this 
Increase. In 1955, Brehm suggested that cardiac output may be 
regulated by peripheral resistance and that maternal hormones were a 
fundamental cause of cardiac variation. Exogenous estrogen 
administration was studied by Parer and Ueland in ewes (24). They 
showed that cardiac output and heart rate were elevated and mean 
arterial pressure and peripheral resistance decreased. These changes 
were similar to those seen In pregnant ewes (25). Other studies of 
women taking oral contraceptives have also demonstrated Increased 
cardiac output, stroke volume, blood volume and blood pressure 
(25,27). In one study, progesterone and estrogen were administered 
separately (28). Cardiovascular changes similar to those in pregnancy 
were seen only in those patients given estrogen. Studies in our 
laboratory on guinea pigs chronically receiving progesterone and/or 
estrogen conf lrm these observations. Estrogen treated animals had 
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slgnlf lcant Increases In cardiac output, stroke volume, blood volume 
and left ventricular chamber size compared to controls, essentially 
mimicking the hemodynamlc changes seen In pregnancy. Several studies 
of hormone receptors have shown that the heart and major arteries have 
estrogen and androgen receptors, suggesting that the central cardio-
vascular system may be a target organ for these hormones (29,30,31,32). 
A fal I In systemic vascular resistance appears to be common to 
most, If not al 1, Instances where cardiac enlargement occurs 
(pregnancy, estrogen administration, A-V fistula). To test the 
hypothesis that systemic vascular resistance has a primary role In 
determining left ventricular chamber size, hydralazlne (an arterial 
dilator) was administered chronlcal ly to guinea pigs. 
METHODS 
Choice Qf Experimental Animal 
Male guinea pigs were chosen as the experimental model tor this 
study. Substantial I lterature exists using guinea pigs as models tor 
cardiovascular physiologic Investigation (3,13,33,34,35,36,37). 
Males were used to avoid any estrus related hormone varlabll lty. The 
guinea pig Is relatively smal I and easy to handle, but large enough 
tor thorough hemodynamlc Investigation. In addition, the Heart 
Research Laboratory has had extensive experience with this animal 
(13,38,39). The above reasons made the guinea pig an attractive model 
tor the study of maternal cardiovascular physiology. 
Choice Qf Pharmacologlc Dr:..ug 
Hydralazlne was chosen as the drug to reduce vascular resistance 
primarily because of Its mechanism of action: relaxation of arterial 
smooth muscle, particularly at the arterioles (40). It has no direct 
effects on the autonomic nervous system (40) nor any known direct 
effects on the cardiac muscle. Chronic administration of hydralazlne 
has been used In rodents with the appropriate fal I In systemic 
vascular resistance (41). Finally, the extensive use of hydralazlne 
In treatment of hypertension and congestive heart failure cl lnlcal ly 
adds Interest to experimental results (42,43). 
Determination Qf Dr:..ug Q.Q.se. 
Dose testing was performed using two separate protocols. The 
f lrst group was dosed subcutaneously by Implantation of hydralazlne 
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tablets Chydralazlne with cholesterol, lactose, and methylcel lulose). 
These animals were first anesthetized with ketamlne/xylazlne (see 
Instrumentation). An Incision In the neck was made and the carotid 
artery was Isolated and cannulated with a polyvinyl catheter (see 
Instrumentation). The catheter was tunneled to the ventral part of 
the neck, fll led with heparin (500 units/ml) and capped. This 
catheter al lowed blood pressure, and heart rate measurements to be 
made. Basel lne weights, blood pressure, and heart rates were taken 
and compared with post-Implantation measurements every other day. 
Measurements were continued until blood pressures returned to 
basel lne. 
The second protocol differed only In the form of hydralazlne 
administration. These animals were dosed orally via their drinking 
water. Powdered hydralazlne hydrochloride Capresol lne: 1-
hydrazlnophthalazlne) was used. Anesthesia, surgery, dose levels and 
dally measurements were conducted exactly as Jn Protocol 1. 
Both protocols reduced arterial blood pressure by about the same 
amount and for the same duration (see Results). The oral dosing 
method was chosen for this study for two main reasons: Jt was less 
traumatic for the animals, and It was much more convenient to 
administer. 
Animal Preparation 
Thirty male guinea pigs between the weights of 700 and 1000 
grams were matched according to weight and strain (Duncan-Hartley or 
Topeka) and placed Into two groups: treated and control. The animals 
were purchased from and housed In the Oregon Health Sciences 
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University Department of Animal Care. The housing Included continuous 
access to food and water, a 12-hour I lght cycle, and a constant room 
temperature of 21 degrees centigrade. The treated group was given 
hydralazlne in their drinking water dally for three weeks. The 
beginning dose was 5 mg/kg/day. At the beginning of weeks 2 and 3 the 
dose was Increased by an additional 5 mg/kg/day. During the three 
weeks, animal water consumption was randomly measured to verify that 
dosing was consistent (evaporation was accounted for). At the end of 
three weeks animals were Instrumented and studied. 
Instrumentation 
On the appropriate day, animals were given an Intramuscular 
Injection of ketamlne (25 mg/kg) and xylazlne C0.15 mg/kg) to provide 
a surgical level of anesthesia (44). Ketamlne acts as a dissociative 
anesthetic and xylazlne as a non-narcotic sedative and muscle 
relaxant. The combination of these two drugs Is often used to 
provide anesthesia during Invasive Instrumentation. Cardiovascular 
effects of this combination have been Investigated In the guinea pig 
(44). Adequate anesthesia Is provided for approximately 90 minutes 
and by 3 hours post Injection hemodynamlcs have returned to base I lne. 
This time period provides ample time to Instrument the animals and 
al low them to recover so that the studies can be performed In one day 
without altering hemodynamlc measurements. Surgery was performed 
under clean but not sterile conditions. A transverse ventral Incision 
was made In the neck. The jugular vein and carotid artery were 
Isolated and cleaned of fat and connective tissue. A thermodllutlon 
probe (Edwards Lab 1.5F) was inserted into the carotid artery and 
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advanced retrograde 4 cm Into the ascending aorta. A second Incision 
was made In the right groin and the superf lclal saphenous artery was 
Isolated. A polyvinyl catheter C0.9 mm O.D., 0.5 mm l.D.> was 
Inserted and advanced 6 cm retrograde Into the abdominal aorta. 
Placement of catheters was verlf led by pressure monitoring. Catheters 
were then tunneled subcutaneously to the dorsal part of the neck, 
flt led with heparin solution (150 units/ml), capped and secured until 
the time of study. Animals were placed In a large recovery cage and 
al lowed free access to food and water • 
.s.t.u.d¥ 
Animals were al lowed to recover for 6 to 7 hours post anesthesia 
Injection. At this time animals were placed In a study cage which 
permitted I lttle movement. The animals were left In the darkened, 
quiet room for a 30-mlnute accl Imation period. 
Resting values tor systolic, diastolic, and mean blood pressures, 
as wel I as respiratory and heart rates were measured simultaneously 
using Statham P-23 Gb pressure transducers zeroed to mid-chest and 
displayed on a Gilson 5/6 strlpchart recorder. A typical pressure 
recording Is shown In Figure 1. 
Cardiac output was determined using the thermodilution method. 
Thermodllution cardiac outputs were performed as fol lows: 0.4 
mil Ill iters of room temperature saline were injected as a bolus Into 
the right atrial catheter. Temperature change was registered by the 
thermistor probe, and cardiac output was calculated with a dedicated 
thermodilution cardiac output computer (Edwards Laboratories Model 
9520A) using the formula: 
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{ p Co ( b I ood ) J T Tb ( t ) dt + c} 
0 
where CO= cardiac output, pCo =density x specif le heat of the 
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lnjectate or blood, VJ = lnjectate volume, Ct= dead space correction 
factor, Tb = blood temperature, Tl = lnjectate temperature, T = 30% of 
T 
peak value of descending I lmb of thermodllutlon curve, f Tb (t) dt = 
0 
area under the thermodllutlon curve to T, and c = ranalnlng area 
under the thermodllutlon curve (45). Based upon the volume of the 
lnjectate, the dead space and calculated heat loss using the right 
atrial catheter, a computation constant Cl.08 Ct (60) VI) of 0.20 was 
utll lzed. A typical thermodllutlon curve Is shown Jn Figure 2. 
Val ldatlon of this method of cardiac output determination In guinea 
pigs has been performed In our laboratory by comparing thermodllutlon 
cardiac output to aortic flow as measured by cal lbrated electro-
magnetic flow probe. The results are shown Jn Figure 3. The 
correlation between aortic flow and thermodllutlon was 0.88 Cp <0.05). 
The hematocrlt was also determined using packed eel I volumes 
of samples centrifuged for 5 minutes In standard capll iary tubes. 
Blood volume was determined by dye dilution (34). Briefly, 0.40 ml of 
an Evans blue dye CT-1824) standard solution was Infused Into the 
right atrial catheter, fol lowed by 2 ml of sal lne to ensure complete 
del Ivery. After 5 minutes, a 4 ml sample of blood was removed from 
the arterial catheter. The sample was centrifuged and the plasma 
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removed. Dye concentration was measured with a spectrophotometer 
(Coleman Junior II model 6/20) at a wavelength of 620 nm. The 
spectrophotometer was zeroed with a blank plasma reference (taken 
before dye Infusion) from the same animal. Plasma volume was 
calculated from a known standard curve. 
Fol low Ing In vivo studies, In vitro left ventrlcular pressure-
voiume data were generated as fol lows. Animals were anesthetized with 
20 m2 S;o-tat® rnd then lethally Injected with 1 ml of saturated 
potassium chloride Intravenously which resulted In dlastol Jc cardiac 
arrest. The chest was then opened and the heart was removed. The 
right ventricle and atrium were dissected away. A smal I Incision was 
made In the left atrial appendage and a double lumen grooved plug was 
Inserted tc the I eve I of the m I tr al an nu I '-'S (Figure 4). A s 11 k suture 
was tied tightly around the atrial ventricular groove. With the left 
ventricle Isolated and secured the plug was connected to a 10 ml 
syringe on a Harvard Infusion/withdrawal pump and to a Statham p23 Gb 
pressure transducer zeroed at mid-ventricular level. The system was 
Figure4. Apparatus used to isolate left ventricle during 
pressure-volume measurements. 
~ - Pressure 
Transducer 
Infusion - ::f: (, U ~ 
Pump 
15 
f 11 led with sal lne and al I air bubbles flushed out. The left 
ventricle with plug Inserted was suspended In a sat lne-fll led dish. 
lntraventrlcular pressure was measured continuously from zero pressure 
and volume during constant Infusion for 5 to 10 seconds at a 
cal lbrated rate. The pressure was al lowed to reach only 30 mm Hg to 
avoid stretching. A typical pressure-volume curve Is shown In Figure 
5. After three successful curves had been recorded, the left 
ventricle was removed from the plug, cut open, blotted and weighed. 
FIGURE 5 
Utll !zing the cal Jbrated Infusion rate, pressure time recordings 
were converted to pressure-volume values. Values were taken at 0.05 
ml Increments and from 2 to 24 mm Hg, and were compared between 
groups. All pressure-volume studies were completed within 15 minutes 
of KCI Injection. We have noted rigor Ca leftward shift In the 
pressure-volume curve) In the guinea pig Jn no less than 40 minutes. 
Statistics 
Student's t test for non-paired data was used for this Investi-
gation. SJgnlf Icance was considered present If p <0.05. 
RESUI.. TS 
~ Determination .s.:t.u..d¥. 
Figure 6 shows arterial pressures over time for the animals 
dosed subcutaneously and orally with hydralazlne. Arterial pressures 
Initially were 15% below control and returned to control values by day 
14. 
Chronic Dosing .s.:t.u..d¥. 
Fifteen animals were randomized to each study group. Table II 
shows body and left ventricular weights, total plasma volume, and 
hematocrlts. Al I animals gained weight during the study as would be 
expected of healthy, growing animals. Study groups were wel I matched 
as seen by similar mean body weights. 
TABLE II 
Control Treated 
Weight (kg) 0.899 ± 0.805 0.903 ± 0.806 
LV weight (g) 1.355 ± 0.166 1.328 ± 0.153 
Plasma volume (ml) 40. 7 ± 5. 0 43.4 ± 5.5 
Hematocrit 39.5 ± 2.9 39.4 ± 2.8 
Values are mean ± S .D.; n = 15 
TableIITdlsplays the hemodynamlc data for both groups. Systol le 
and diastolic pressures were sl lghtly lower Jn the treated animals but 
the differences were net slgnlf Jcant. Right atrial pressure was not 
different between groups. 
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TABLE III 
Heart rate (beats/min) 
Systolic pressure (mm Hg) 
Diastolic pressure (mm Hg) 
Mean pressure (mm Hg) 
Right atrial pressure (mm Hg) 
Cardiac index (ml/min/kg) 
Stroke volume index (ml/kg) 
Systemic vascular resistance 
LV volume at various pressures: 
2 mm Hg 
4 mm Hg 
6 mm Hg 
8 mm Hg 
10 mm Hg 
12 mm Hg 
14 mm Hg 
Values are mean ± S.D.; n = 15 
Control 
246 ± 33 
83 ± 8 
51 ± 4 
64 ± 5 
0.05 ± 0.70 
230 ± 28 
0.93 ± 0.13 
0.360 ± 0.088 
0.5i3 ± 0.131 
0.769 ± 0.138 
0.915 ± 0.141 
0.998 ± 0.147 
1. 0 58 ± 0 . 14 9 
1.020 ± 0.301 
1.142 ± 0 .156 
Treated 
249 ± 27 
79 ± 10 
51 ± 7 
62 ± 9 
18 
0.93 ± 1.40 
241 ± 35 
0.97 ± 0.15 
0.319 ± 0.071 
0.559 ± 0.127 
0.796 ± 0.105 
0.930 ± 0.093 
1.019 ± 0.095 
1.075 ± 0.099 
1.121 ± 0.105 
1.157 ± 0 .108 
19 
Cardiac output was normal !zed to body weight so that different 
sized animals could be more accurately compared. Cardiac "Index" 
(cardiac output/body weight) was sl lghtly higher In the treated group 
and systemic vascular resistance lower, but the differences were not 
slgnlf lcant. Stroke volumes were the same for both groups. 
Plasma volume was slightly elevated In the treated 
group but not statlstlcal ly different. Hematocrlt was the same for 
both groups. 
Left ventrlcular weights were the same for both groups. Left 
ventrlcular size at any given pressure was sllghtly larger for the 
treated group (Figure 7), but again, not significant. 
14
 
12
 
LE
FI 
19
 
U\~
fsi
s~R
~R 
8 
(M
M
ffg
) 
6 4 
LE
FT
 U
EN
TR
ICU
LA
R 
PR
ES
SU
RE
-UO
LU
ME
 D
AT
A t 
.
~
 
• 
Co
ntl
'ol
 
~ 
·
~
 
• 
Tk
'ea
ted
 
f 
• 
~
 
I 
I 
1-
-f
 
I 
t
~
 
f 
t 
I 
I 
2
..
.-
--
--
..
.-
--
--
--
--
--
--
-.
..
--
--
--
..
..
.-
--
--
-
9,7
 
9.8
 
9.9
 
1 
1.1
 
1.2
 
LE
FT
 U
EN
TR
ICU
LA
R 
UO
LU
ME
 (
M
l/k
g)
 
FI
G
U
R
E 
7 
(V
al
ue
s 
ar
e 
m
ea
n 
±
 S
.E
.;
 
n 
=
 15
) 
N
 
C
>
 
DISCUSSION 
This study demonstrates the dlff lcultles associated In 
attempting to change hemodynamlc homeostasis chronlcal ly. Despite 
large doses of hydralazlne given orally, systemic vascular resistance 
was only mildly affected at three weeks. Along with the smal I 
decrease In systemic vascular resistance, a smal I decrease In blood 
pressure was observed, as wel I as a slight rise In cardiac Index and 
stroke volume Index. Also, left ventricular chamber size tended to be 
larger at any given fll ling pressure for the hydralazlne treated 
animals. Although no changes I lsted above were statistically 
significant, the direction of the changes Is similar to that seen In 
pregnancy or sex steroid administration (12,13). 
Hydralazlne was administered orally. The decision to use 
hydralazlne was based on several criteria: 1) hydralazlne Is easy to 
administer when dissolved In water; 2) hydralazlne Is easily absorbed; 
3) hydralazlne has a bloavallabll lty of 30-50% which can be Increased 
If given simultaneously with sol Id food; 4) the area of action appears 
to be only on smooth muscle with no direct cardiac effects or effects 
on regulatory systems (40). Other potential vasodllators Include 
captoprfl, prazosfn, phentolamlne, and nltroprusslde. These drugs 
were not used because of their potential effects on cardiac muscle 
directly, on complex Interaction with renal function, and/or the 
autonomic nervous system. Additionally, side effects associated with 
these drugs may have compl Jcated the Investigation. 
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Subacute hemodynamlc measurements were used for this study 
rather than chronic measurements. This helped to Insure that animals 
were tree from Infection at the time of study and also Insured a high 
percentage of catheter patency. Furthermore, this laboratory has 
demonstrated that subacute hemodynamlcs fol low Ing ketamlne/xylazlne 
anesthesia accurately reflects chronic hemodynamlcs In the guinea pig 
(44). 
In vitro passive pressure volume curves were used to evaluate 
left ventricular chamber size. It has been recognized that the In 
vitro pressure-volume relationship Is only onE of several factors that 
determines pressure-volume relations In vivo ( >6). Other factors 
Include restraint caused by simultaneous right ventricular pressure 
(47), the percardlum (46), and coronary artery pressure (48). Despite 
these additional Influences, the left ventricular pressure-volume 
relationship Is a primary determinant of left ver.Trlcular chamber size 
In vivo. 
The thermodllutlon method of determining cardiac output was 
utll lzed In this study. We felt justified In using this method as It 
has been val I dated directly In our laboratory by simultaneous 
comparison with aortic flow In the guinea pig. Other potential 
optlons for determining cardlac output In smal I animals Include the 
Fick method and the microsphere Indicator dilution technique. The 
Fick method would require pulmonary artery catheterlzatlon and the 
additional restraint of the animal In a sealed chamber while 
attempting to measure restlng hemodynamlcs. The use of mlcrospheres 
requires handling of radloactlve Jsotopes which are costly and requlre 
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special disposal. In addition, multlple cardiac output determinations 
within a single animal require multiple labels. Thermodilutlon al lows 
for repeated measurements In a single animal easily and reproducibly. 
Hydralazlne was used to Increase the diameter of the resistance 
vessels (49,50,51). A larger vessel provides less resistance and 
permits more flow: 
Q = 6 p TI R4 
Bnt 
where !:c.P =the change In pressure along a vessel, R =the radius of 
the vessel, n =the viscosity of the fluid, and £=the length of the 
vessel. Systemic vascular resistance ls calculated using a 
hemodynamlc adaptation of Ohm's law from the formula: R = map-rap/CO, 
where map Is mean arterial pressure, rap Is right atrial pressure, and 
CO Is cardiac output. Units are In Pru's (peripheral resistance 
units) or Wood units. A change Jn systemic vascular resistance would 
be Indirectly shown by an Increase in cardiac output and/or a decrease 
In mean arterial pressure. During prel lmlnary dosing studies It was 
possible to monitor blood pressure for up to two weeks. The fact that 
blood pressure was generally decreased Indicated that systemic 
vascular resistance was probably being decreased also (there was no 
reason to expect that cardiac output would have decreased). 
The diff lcultles of maintaining a decreased systemic vascular 
resistance for three weeks may have been a result of hemodynamlc 
compensation. The effects of vasodllatlon, Jn particular decreased 
blood pressure, can be countered by many physlologlc mechanisms. The 
two major categories of blood pressure control mechanisms are short 
and long term regulation. 
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One of the primary short-term blood pressure control mechanisms 
Is the baroceptors. Baroreceptor (presser) reflexes, which sense a 
drop In pressure, decrease Inhibitory Impulses to the vasoconstrlctlon 
center and stop excitation of the vagal center. Chemoreceptors 
responding to Increased carbon dioxide molecules and hydrogen Ions, 
and to decreased oxygen avallabll lty (due to decreased flow) excite 
nerve f lbers leading to the vasomotor center. The f lnal response Is 
the same as that of the baroreceptors. Diminished blood flow due to 
acute vasodllatlon may also cause an lschemla In the brain el felting a 
direct excitation of the vasomotor center. This causes a strong 
sympathetic response resulting In systemic vasoconstrlctlon. Although 
this lschemla mechanism Is usually augmented only In severe pressure 
loss situations, It Is very powerful. 
In addition to rapidly acting nervous mechanisms for blood 
pressure control, there are several hormonal mechanisms that also 
provide acute or subacute compensation. Sympathetic stimulation 
resulting from the above mechanisms causes release of epinephrine and 
noreplnephrlne from the adrenal medulla Into the clrculatlon. The 
Increased adenerglc activity stimulates beta receptors to Increase 
heart rate and contractll lty. Alpha receptors are stimulated to 
produce vasoconstrlctlon In the arteries and veins. 
Reduced arterial pressure stimulates the release of renln by the 
juxtaglomerular eel Is of the kidneys, thus producing anglotensln I and 
11. Anglotensln I I Is a powerful vasoconstrlctor and acts acutely on 
the arterioles and venuoles. In addition to the nervous and hormonal 
mechanisms, two other physical mechanisms of the circulation help to 
directly alter blood pressure. These mechanisms are the capll lary 
fluid shift and the vascular stress relaxation mechanisms. 
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Many of these mechanisms may have contributed to compensation 
against the effects of hydralazlne In this study. Short term 
mechanisms In general, however, lose their abll lty to control blood 
pressure after a few hours to a few days. This Is because the nervous 
pressure receptors lose their responsiveness and adapt. During the 
dose study the treated animals had lower blood pressures for up to two 
weeks. This would seem to Indicate that the hydralazlne given was 
effective enough to decrease blood pressure In spite of short term 
compensatory mechanisms. 
A drop In arterial pressure greatly decreases the rate at which 
the kidneys excrete water and salt. This Is the result of the renal-
body f luld mechanlsm. Thls long term mechanism Is complex and not 
completely understood. Briefly, It controls blood pressure primarily 
via blood volume. A decrease In pressure causes the kidneys to 
decrease the output of water and salt. In addition to this pressure 
(diuresis and natrluresls), the low pressure causes Increased secre-
tion of renln by the kidneys, Increased aldosterone secretion by the 
adrenal cortices, and Increased sympathetic signals to the kidneys. 
Al I these In turn decrease the renal output of water and salt by 
various submechanlsms. 
In this study plasma volume was only Increased by 2 ml and was 
not statistically slgnlf lcant In the treated animals. However, It has 
been shown that a two percent increase In blood volume can Increase 
the mean circulatory fll ling pressure by five percent (52). An 
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Increase Jn cardiac output of f lve percent can Increase systemic 
vascular resistance 25-50%. These figures suggest that a two percent 
Increase In blood volume may Increase arterial pressure 30-57%. A 
smal I Increase Jn blood volume may therefore have been enough to cause 
blood pressure to stay near normal Jn the hydralazlne treated animals. 
Of the many mechanisms that work to regulate blood pressure 
directly and systemic vascular resistance Indirectly, only one was the 
focus of this study: that of local vasomotlon. It ls possible that 
compensatory mechanisms such as the renal fluid-body and renln-
anglotensln mechanisms were engaged to such a degree that treated 
animal hemodynamics remained In normal ranges. One way to further 
address this problem would be to manipulate more than one hemodynamlc 
control mechanism at a time. For example, a future study could 
vasodllate locally as In this study and at the same time Inhibit 
anglotensln with a drug such as captoprll. Then a portion of both the 
long and short term control systems would be affected. 
This study was unable to provide conclusive evidence that 
systemic vascular resistance ls a signal for heart size. The primary 
dlfflcultles experienced seemed to stem from an lnabll ity to maintain 
a decreased systemic vascular resistance. The hypothesized results 
appeared Jn the form of trends al I Jn the expected directions 
(increased cardiac output, left ventricular chamber size, and stroke 
volume), but were not statistically significant. In order to study 
the effects of systemic vascular resistance on heart size, future 
studies may have to direct efforts of control ling more than one 
hemodynamlc control mechanism. This could be accompl I shed with 
multiple drugs administered simultaneously. 
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